Allarity Therapeutics, Inc.
ALLR
$1.61
-$0.15-8.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -42.42% | 28.91% | -332.81% | -160.63% | 31.55% |
| Total Depreciation and Amortization | 1,100.00% | 450.00% | -88.89% | -44.44% | -88.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 111.83% | 141.35% | 109.89% | 959.00% | -67.85% |
| Change in Net Operating Assets | 4.68% | -105.16% | 12.31% | -73.79% | -420.64% |
| Cash from Operations | 24.96% | -91.99% | -91.75% | -1.25% | -192.63% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | 59.98% |
| Issuance of Common Stock | -100.00% | 27,757.50% | 709.75% | -53.98% | 305.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | 30.00% | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -109.75% | 707.46% | 711.30% | -24.53% | 818.29% |
| Foreign Exchange rate Adjustments | -2,110.71% | -273.33% | 508.43% | -105.26% | 65.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -152.34% | 5,496.58% | 186.78% | -178.65% | 15,036.80% |